Press Releases about Cencora Inc
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Cencora
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Cencora
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
February 07, 2024
From Cencora
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://mms.businesswire.com/media/20240207027727/en/2026194/22/Cencora_Logo_Standard_Blue_RGB.jpg)
![](https://mms.businesswire.com/media/20240205856996/en/2023250/22/Cencora_Logo_Standard_Blue_RGB.jpg)
Cencora Prices $500 Million 5.125% Senior Notes Due 2034
February 05, 2024
From Cencora
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Cencora
Via Business Wire
![](https://www.marketbeat.com/logos/articles/med_20231127184258_teva-pharma-is-the-way-to-play-the-re-rise-of-gene.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
November 09, 2023
From Cencora
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
November 02, 2023
From Cencora
Via Business Wire
![](https://www.marketbeat.com/logos/articles/med_20231008191414_eli-lilly-mckesson-novartis-flash-promising-chart.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.